| MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression … S Hu, ZY Xu-Monette, A Tzankov, T Green, L Wu, A Balasubramanyam, ... Blood, The Journal of the American Society of Hematology 121 (20), 4021-4031, 2013 | 776 | 2013 |
| Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma J Iqbal, DD Weisenburger, TC Greiner, JM Vose, T McKeithan, C Kucuk, ... Blood, The Journal of the American Society of Hematology 115 (5), 1026-1036, 2010 | 403 | 2010 |
| Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large … C Visco, Y Li, ZY Xu-Monette, RN Miranda, TM Green, A Tzankov, W Wen, ... Leukemia 26 (9), 2103-2113, 2012 | 387 | 2012 |
| Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP … ZY Xu-Monette, L Wu, C Visco, YC Tai, A Tzankov, W Liu, ... Blood, The Journal of the American Society of Hematology 120 (19), 3986-3996, 2012 | 366 | 2012 |
| CD30 expression defines a novel subset of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from The International DLBCL … S Hu, ZY Xu-Monette, A Balasubramanyam, GC Manyam, C Visco, ... Blood, 2013 | 265 | 2013 |
| Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies J Iqbal, C Kucuk, RJ Deleeuw, G Srivastava, W Tam, H Geng, D Klinkebiel, ... Leukemia 23 (6), 1139-1151, 2009 | 211 | 2009 |
| Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International … C Visco, A Tzankov, ZY Xu-Monette, RN Miranda, YC Tai, Y Li, W Liu, ... Haematologica 98 (2), 255, 2013 | 190 | 2013 |
| Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP A Tzankov, ZY Xu-Monette, M Gerhard, C Visco, S Dirnhofer, N Gisin, ... Modern pathology 27 (7), 958-971, 2014 | 158 | 2014 |
| Prevalence and Clinical Implications of Epstein–Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries CY Ok, L Li, ZY Xu-Monette, C Visco, A Tzankov, GC Manyam, ... Clinical Cancer Research 20 (9), 2338-2349, 2014 | 145 | 2014 |
| Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma J Iqbal, Y Shen, X Huang, Y Liu, L Wake, C Liu, K Deffenbacher, ... Blood, The Journal of the American Society of Hematology 125 (7), 1137-1145, 2015 | 131 | 2015 |
| Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways K Dybkaer, J Iqbal, G Zhou, H Geng, L Xiao, A Schmitz, F d'Amore, ... BMC genomics 8, 1-17, 2007 | 124 | 2007 |
| Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis K Dybkær, M Bøgsted, S Falgreen, JS Bødker, MK Kjeldsen, A Schmitz, ... Journal of Clinical Oncology 33 (12), 1379, 2015 | 115 | 2015 |
| Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma Q Ye, ZY Xu-Monette, A Tzankov, L Deng, X Wang, GC Manyam, C Visco, ... Oncotarget 7 (3), 2401, 2016 | 114 | 2016 |
| Human papillomavirus infection as a possible cause of spontaneous abortion and spontaneous preterm delivery LMM Ambühl, U Baandrup, K Dybkær, J Blaakær, N Uldbjerg, S Sørensen Infectious diseases in obstetrics and gynecology 2016, 2016 | 105 | 2016 |
| Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL ZY Xu-Monette, M Xiao, Q Au, R Padmanabhan, B Xu, N Hoe, ... Cancer immunology research 7 (4), 644-657, 2019 | 103 | 2019 |
| MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma C Liu, J Iqbal, J Teruya-Feldstein, Y Shen, MJ Dabrowska, K Dybkaer, ... Blood, The Journal of the American Society of Hematology 122 (12), 2083-2092, 2013 | 101 | 2013 |
| Long noncoding RNA expression during human B-cell development A Petri, K Dybkaer, M Bøgsted, CA Thrue, PH Hagedorn, A Schmitz, ... PloS one 10 (9), e0138236, 2015 | 97 | 2015 |
| Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries ZY Xu-Monette, M Tu, KJ Jabbar, X Cao, A Tzankov, C Visco, Q Cai, ... Oncotarget 6 (8), 5615, 2015 | 95 | 2015 |
| Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review ML Madsen, H Due, N Ejskjær, P Jensen, J Madsen, K Dybkær Cancer chemotherapy and pharmacology 84, 471-485, 2019 | 87 | 2019 |
| Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma ZY Xu-Monette, L Li, JC Byrd, KJ Jabbar, GC Manyam, C Maria de Winde, ... Blood, The Journal of the American Society of Hematology 128 (26), 3083-3100, 2016 | 78 | 2016 |
